situation épidémiologique de l’infection à...
TRANSCRIPT
![Page 1: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/1.jpg)
Session 1
![Page 2: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/2.jpg)
Module goals
![Page 3: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/3.jpg)
Module 2: Natural history and clinical aspects
natural history and clinical aspects
Mod
ule
1 M
odul
e 2
Mod
ule
3 M
odul
e 4
Participants will be able to: -offer an insight into the epidemiological situation in the country and worldwide -present the HIV transmission modes and the broad approaches to prevention -implement post-exposure prophylaxis for HIV in the health care environment.
Participants will be able to: -describe the natural history of the HIV infection -expose the main circumstances in which the HIV infection is discovered -describe some of the clinical manifestations of the HIV/AIDS infection.
Participants will be able to: - name the techniques used for the biological diagnosis of the HIV infection - argue the need to comply with ethical and confidentiality imperatives in the health care environment - name the interventions to reduce HIV stigma and discrimination in health care settings.
Participants will be able to: - inform a PLHIV about how care is organized in the country - inform a PLHIV about the principles of care - inform parents about the care available for a newborn baby, infant or child infected by HIV - argue the need for optimal adherence to antiretroviral therapy.
![Page 4: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/4.jpg)
Module 2: Natural history and clinical aspects
natural history and clinical aspects
Mod
ule
1 M
odul
e 2
Mod
ule
3 M
odul
e 4
Participants will be able to: -offer an insight into the epidemiological situation in the country and worldwide -present the HIV transmission modes and the broad approaches to prevention -implement post-exposure prophylaxis for HIV in the health care environment.
Participants will be able to: -describe the natural history of the HIV infection -expose the main circumstances in which the HIV infection is discovered -describe some of the clinical manifestations of the HIV/AIDS infection.
Participants will be able to: - name the techniques used for the biological diagnosis of the HIV infection - argue the need to comply with ethical and confidentiality imperatives in the health care environment - name the interventions to reduce HIV stigma and discrimination in health care settings.
Participants will be able to: - inform a PLHIV about how care is organized in the country - inform a PLHIV about the principles of care - inform parents about the care available for a newborn baby, infant or child infected by HIV - argue the need for optimal adherence to antiretroviral therapy.
![Page 5: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/5.jpg)
Natural history of the HIV infection
![Page 6: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/6.jpg)
Module 2: Natural history and clinical aspects
natural history and clinical aspects
Natural history
Exposure Infection No infection Primary infection Asymptomatic HIV-positive
10 years later
- Non-progressor 5%–10% - Minor infections 20% - AIDS 70%
![Page 7: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/7.jpg)
Module 2: Natural history and clinical aspects
natural history and clinical aspects
Evolution of CD4 and viral load
years
200
4 8 2 10
![Page 8: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/8.jpg)
Module 2: Natural history and clinical aspects
natural history and clinical aspects
Two essential parameters (CD4 and viral load)
Viral load
Speed
![Page 9: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/9.jpg)
Module 2: Natural history and clinical aspects
natural history and clinical aspects
Destruction of CD4
Normal HIV infection
CD4 CD4
![Page 10: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/10.jpg)
Module 2: Natural history and clinical aspects
natural history and clinical aspects
Consequences of the reduction of CD4 T lymphocytes
Immune system intact
Immune system destroyed
Loss of defence mechanisms
![Page 11: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/11.jpg)
Module 2: Natural history and clinical aspects
natural history and clinical aspects
Clinical and biological correlation
years
200
Tumours
Opportunistic infections
4 8
AIDS
2 10
PI Asymptomatic Minor infections
HIV encephalitis
![Page 12: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/12.jpg)
Module 2: Natural history and clinical aspects
natural history and clinical aspects
Rate of CD4 decline and occurrence of Opportunistic Infections
years
200
Candidiasis
Herpes Zoster
Kaposi’s sarcoma
Lymphoma
Pneumocystosis
Toxoplasmosis
CMV Atypical
mycobacterioses
4 8
AIDS
2 10
PI Asymptomatic
![Page 13: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/13.jpg)
Module 2: Natural history and clinical aspects
natural history and clinical aspects
• Can modify the natural history of HIV infection
• Can inhibit viral multiplication and consequently restore cell
immunity
Antiretroviral therapy
![Page 14: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/14.jpg)
Classifications of HIV infection
![Page 15: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/15.jpg)
Module 2: Natural history and clinical aspects
natural history and clinical aspects
Rate of CD4 decline and occurrence of opportunistic infections
years
200
Candidiasis
Herpes Zoster
Kaposi’s sarcoma
Lymphoma
Pneumocystosis
Toxoplasmosis
CMV
4 8
AIDS
2 10
PI Asymptomatic
Atypical mycobacterioses
![Page 16: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/16.jpg)
Module 2: Natural history and clinical aspects
natural history and clinical aspects
Cases of HIV infection are classified as follows
•According to clinical manifestations: primary infection,
general signs, minor infections, opportunistic infections, HIV-
related tumours…
•According to degree of immunodeficiency: CD4 T lymphocyte
count
•According to age: adults and adolescents, children
Basis of classification
![Page 17: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/17.jpg)
Module 2: Natural history and clinical aspects
natural history and clinical aspects
WHO classification
• Stage I: asymptomatic infection or lymphadenopathy
• Stage II: moderate infection
• Stage III: advanced infection
• Stage IV: severe infection
CDC classification (Centers for Disease Control and Prevention, Atlanta)
Category A, B and C
Definition of AIDS: depends on choice of classification
Different classifications
![Page 18: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/18.jpg)
Module 2: Natural history and clinical aspects
natural history and clinical aspects
Classification used in the country
![Page 19: Situation épidémiologique de l’infection à VIH/sidaapplications.emro.who.int/dsaf/EMROPUB_2015_EN_1884_session1.pdfHIV encephalitis . Module 2: Natural history and clinical aspects](https://reader030.vdocuments.us/reader030/viewer/2022040807/5e4a4f7eda8b9679d27706c0/html5/thumbnails/19.jpg)
Module 2: Natural history and clinical aspects
natural history and clinical aspects
Definition of AIDS used in the country